![Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC) Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC)](https://publichealthcollaborative.org/wp-content/uploads/2022/10/ENG_Twitter_updated-booster-doses-2.png)
Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC)
![COVID vaccinations: questions and answers about the rollout in North Yorkshire - NHS North Yorkshire CCG COVID vaccinations: questions and answers about the rollout in North Yorkshire - NHS North Yorkshire CCG](https://northyorkshireccg.nhs.uk/wp-content/uploads/2022/01/Covid-Vaccine-Eligibility-v4-scaled.jpg)
COVID vaccinations: questions and answers about the rollout in North Yorkshire - NHS North Yorkshire CCG
![La Moncloa. 11/11/2022. More than 60% of people aged over 80 years have a second booster dose of COVID-19 [Government/News] La Moncloa. 11/11/2022. More than 60% of people aged over 80 years have a second booster dose of COVID-19 [Government/News]](https://www.lamoncloa.gob.es/serviciosdeprensa/notasprensa/sanidad14/PublishingImages/Recursos/150321vacunas3.jpg)
La Moncloa. 11/11/2022. More than 60% of people aged over 80 years have a second booster dose of COVID-19 [Government/News]
![Coronavirus in Spain: Guide to the Covid-19 booster shot in Spain: Who is eligible and when will it be available? | Society | EL PAÍS English Coronavirus in Spain: Guide to the Covid-19 booster shot in Spain: Who is eligible and when will it be available? | Society | EL PAÍS English](https://images.english.elpais.com/resizer/HTIBKCArvxzdg7WjPV3nbXjPtNU=/1960x1103/filters:focal(701x248:711x258)/cloudfront-eu-central-1.images.arcpublishing.com/prisa/6573A322X5DZJP3G2Z46WB6YG4.jpg)
Coronavirus in Spain: Guide to the Covid-19 booster shot in Spain: Who is eligible and when will it be available? | Society | EL PAÍS English
![Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study - The Lancet Infectious Diseases Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/ee130977-a19d-4087-8be9-e8c163aab599/gr1.gif)